Abstract:Intravenous (IV) thrombolysis is currently the most established treatment for acute ischemic stroke 1. Traditionally, patients with unruptured intracranial aneurysms have been deemed ineligible due to a theoretical increased risk of intracranial hemorrhage (ICH) from post-thrombolytic rupture of aneurysm. Recently, four retrospective studies indicated no significant difference in symptomatic ICH after intravenous thrombolysis between stroke patients with or without intracranial aneurysms 2-5. However, in most of these patients, the ischemic stroke mechanism was unrelated to the unruptured intracranial aneurysm. The safety of IV thrombolysis in acute ischemic stroke in the same territory of unruptured intracranial aneurysms remains unknown. We therefore present a case of pontine infarction due to a large unruptured intracranial aneurysm (17 mm in diameter) of the basilar artery where the patient received IV recombinant tissue plasminogen activator (rtPA) thrombolysis based on multimodal MR imaging. A 59-year-old man was admitted to the emergency room with a 4-h history of abrupt-onset right hemiparesis and dysarthria. He reported that the symptom severity increased during transport to the hospital. The patient had a past medical history of treated hypertension for 20 years and known basilar artery aneurysm for 2 years that had been managed conservatively. His blood pressure was 160/102 mmHg on admission. Neurological examination revealed normal conscious state, dysarthria, right hemiparesis, and sensory loss. His score on the National Institutes of Health Stroke Scale (NIHSS) was 6. A brain magnetic resonance imaging (MRI) scan (3.0T) was performed immediately. Diffusion-weighted imaging (DWI) revealed increased signal intensity in the left ventral pons (Figure 1A), indicating the presence of hyperacute infarction. Magnetic resonance angiography (MRA) showed a large unruptured intracranial aneurysm of the basilar artery (17 mm in maximal diameter) without basilar artery occlusion (Figure 1B). IV rtPA was administered immediately at a dose of 0.9 mg/kg body weight. His focal neurological deficit dramatically improved by the next morning. Twenty-four hours later, he was also administered an antiplatelet agent (aspirin 200 mg). He made a complete recovery and was discharged 6 days later (NIHSS 0). Our patient did not have any evidence of aneurysm rupture or ICH on his initial susceptibility-weighted imaging (SWI) scan, or on computed tomographic (CT) scan 2 h after thrombolysis (Figure 1C), and SWI at 24 h. There was no evidence of atherosclerotic disease on cervical CT angiography or carotid duplex ultrasonography. Noncontrast and contrast-enhanced T1 fast spin echo (FSE) sequences demonstrated abnormal blood flow with partial thrombosis of the aneurysm (Figure 2A and B). We hypothesize that the abnormal flow within the aneurysm (Figure 2C) leads to gradual thrombosis. Approximately 9.3% of stroke patients receiving intravenous thrombolysis have incidental aneurysms 2. Sometimes the intracranial aneurysms which presence is already known either being managed conservatively or already treated with clipping or coil embolization. On other occasions, the aneurysm is diagnosed during multimodal imaging performed to investigate the stroke. In acute stroke patients with pre-existing intracranial aneurysms, recent studies have suggested that intravenous thrombolysis may be safe given the similar rates of hemorrhagic transformation 2-5 and favorable 3-month clinical outcomes 5. There has been one report of anterior-communicating artery aneurysm rupture after IV rtPA for acute ischemic stroke 6. However, this case may have had a sentinel bleed from an intracranial aneurysm before the onset of ischemic stroke symptoms. Thus, it does highlight the necessity of carefully excluding previous aneurysm rupture before the administration of rtPA. Symptomatic acute ischemia in the territory of an unruptured intracranial aneurysm occurs rarely (approximately 1.3% of ischemic stroke patients) 7. Only two patients who have received thrombolysis in this context have been previously reported. One patient had a left middle cerebral artery aneurysm and received intravenous rtPA for their stroke 8. The other had a basilar tip aneurysm, and the stroke was treated with delayed intra-arterial rtPA 9. The largest aneurysms reported in patients who received rtPA have been approximately 8 mm in diameter 2, 3. Our case is the first report of acute ischemic stroke associated with an unruptured large intracranial aneurysm (17 mm diameter) of the basilar artery with successful treatment using IV rtPA. According to multimodal imaging analysis, thrombus was clearly observed in the aneurysm of the basilar artery. We hypothesize that the pontine infarct may have a potential association with the thrombus in the aneurysm. The fresh extension of intraluminal thrombus may have had lower platelet content, making it more susceptible to pharmacological thrombolysis. In conclusion, whilst it is difficult to estimate the risk of ICH after thrombolysis in acute ischemic stroke patients associated with intracranial aneurysms, our case indicates that at least some patients may benefit from IV rtPA. This case also suggests that multimodal imaging may assist physicians to identify the stroke mechanism and predict response to thrombolytic therapy. Dr. Lou receives research support from Zhejiang Provincial Natural Science Foundation of China (LR12H09001), the National Natural Science Foundation of China (81171095), and the Health Bureau of Zhejiang Province (WKJ2010-2-010). We thank Prof. Bruce Campbell (Royal Melbourne Hospital, University of Melbourne, Parkville, Vic., Australia) for English language correction. The authors have no actual or potential conflicts of interest to disclose.

Post-Thrombolysis Hemorrhage Risk of Unruptured Intracranial Aneurysms

New Cerebral Microbleeds and Mechanism of Post-Thrombolysis Remote Intracerebral Hemorrhage: “red Meets White” Revisited†

Association of Atrial Fibrillation with Remote Intracerebral Hemorrhage after Intravenous Thrombolysis: Results from a Multicenter Study in China.

[Safety of Intravenous Thrombolysis in Cerebral Microbleeds Patients with Prior Antiplatelet Therapy].

Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis.

No Hemorrhagic Transformation after Intravenous Thrombolysis in a Pontine Infarction Patient with Basilar Aneurysm.

Early Fibrinogen Depletion and Symptomatic Intracranial Hemorrhage after Reperfusion Therapy.

Safety of Intravenous Thrombolysis in Chronic Intracranial Hemorrhage: A Five-Year Multicenter Study

Prevalence, risk factors, and clinical outcomes of remote intracerebral hemorrhage after intravenous thrombolysis in acute ischemic stroke: a systematic review and meta-analysis

Intracerebral hemorrhage risk after adjunct intraarterial thrombolysis in thrombectomy-treated acute ischemic stroke

Safety and efficacy of intravenous thrombolysis in acute ischemic stroke patients with a history of intracranial hemorrhage: A systematic review and meta-analysis

Risk factors for intracranial hemorrhage after mechanical thrombectomy: a systematic review and meta-analysis

Effect of post thrombolytic intracerebral hemorrhage volume on 90-day outcomes in acute ischemic stroke patients

Is It Dangerous to Treat Spontaneous Intracerebral Hemorrhage by Minimally Invasive Surgery Plus Local Thrombolysis in Patients with Coexisting Unruptured Intracranial Aneurysms?

Symptomatic post-thrombolytic intracerebral hemorrhage is not related to the cause of stroke

Abstract TMP81: Effect of Post Thrombolytic Intracerebral Hemorrhage Volume on 90-day Outcomes in Acute Ischemic Stroke Patients

Effect of Bleeding Risk Prediction on Decision Making of Intravenous Thrombolysis Before Thrombectomy: a Subgroup Analysis of DIRECT-MT.

Prognosis associated with asymptomatic intracranial hemorrhage after acute ischemic stroke: a systematic review and meta-analysis

The Impact of Cerebral Microbleeds on Intracerebral Hemorrhage and Poor Functional Outcome of Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis: a Systematic Review and Meta-Analysis

Safety of Prophylactic Heparin in the Prevention of Venous Thromboembolism After Spontaneous Intracerebral Hemorrhage: A Meta-analysis

Intrathecal Fibrinolysis for Aneurysmal Subarachnoid Hemorrhage: Evidence from Randomized Controlled Trials and Cohort Studies